Cancer drug research : contrary to allegation, NIH hydrazine sulfate studies were not flawed : report to the chairman and ranking minority member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight /

Bibliographic Details
Corporate Author: United States. General Accounting Office
Format: Government Document Microform Book
Language:English
Published: Washington, D.C. : The Office ; [1995]
Subjects:
Online Access:Adobe Acrobat Reader required

MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000 a 4500
001 in00001403600
007 he bmb024bbca
008 970731s1995 dcua bb f000 0 eng c
005 20230331145545.7
035 |a (OCoLC)ocm37386705 
035 |9 AHM3179AM 
035 |a in00001403600 
037 |a 155070  |b GAO (202) 512-6000 (Voice); (301) 258-4066 (Fax)  |f paper copy 
040 |a GPO  |c GPO  |d DLC  |d MvI  |d UtOrBLW 
042 |a pcc 
043 |a n-us--- 
049 |a UMIC 
049 |a WWW 
074 |a 0546-D (MF) 
074 |a 0546-D (online) 
086 0 |a GA 1.13:HEHS-95-141 
088 |a GAO/HEHS-95-141 
088 |a B-261063 
110 1 |a United States.  |b General Accounting Office. 
245 1 0 |a Cancer drug research :  |b contrary to allegation, NIH hydrazine sulfate studies were not flawed : report to the chairman and ranking minority member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight /  |c United States General Accounting Office. 
246 3 0 |a Contrary to allegation, NIH hydrazine sulfate studies were not flawed 
264 1 |a Washington, D.C. :  |b The Office ;  |c [1995] 
264 2 |a Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) :  |b The Office [distributor], 
300 |a 24 pages :  |b illustrations ;  |c 28 cm. 
336 |a text  |b txt  |2 rdacontent 
337 |a microform  |b h  |2 rdamedia 
338 |a microfiche  |b he  |2 rdacarrier 
500 |a Cover title. 
500 |a Shipping list number: 97-0683-M. 
500 |a "September 1995." 
500 |a Distributed to depository libraries in microfiche. 
504 |a Includes bibliographical references. 
500 |a "GAO/HEHS-95-141." 
500 |a "B-261063"--P. 1. 
533 |a Microfiche.  |b [Washington, D.C.] :  |c U.S. General Accounting Office,  |d [1997?]  |e 1 microfiche : negative. 
530 |a Also available via Internet from the GPO Access web site. Address as of 4/16/2001: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:he95141.pdf; current access is available via PURL. 
500 |a Microform. 
650 0 |a Cancer  |x Chemotherapy  |z United States. 
650 0 |a Antineoplastic agents  |z United States. 
650 0 |a Drugs  |x Research  |z United States. 
610 2 0 |a National Cancer Institute (U.S.) 
856 4 1 |u https://purl.fdlp.gov/GPO/LPS11098  |z Adobe Acrobat Reader required  |t 0 
999 |a MARS 
999 f f |i 50fa7cb0-d5e7-34bd-9351-4bb310d62227  |s 9d45ec5d-bc8b-3b94-8069-b15b813ec832  |t 0 
952 f f |p normal  |a Texas A&M University  |b College Station  |c Sterling C. Evans Library  |d Evans: US Documents Microfiche (3rd floor)  |t 0  |e GA 1.13:HEHS-95-141  |h Superintendent of Documents classification  |i microform -- microfiche  |m A14821678297 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |d Available Online  |t 0  |e GA 1.13:HEHS-95-141  |h Superintendent of Documents classification 
998 f f |a GA 1.13:HEHS-95-141  |t 0  |l Evans: US Documents Microfiche (3rd floor) 
998 f f |a GA 1.13:HEHS-95-141  |t 0  |l Available Online